Velocity Disposable Bipolar Ablators - Product Usage: intended to be used for cutting, vaporizati...
FDA Device Recall #Z-1153-2021 — Class II — February 1, 2021
Recall Summary
| Recall Number | Z-1153-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 1, 2021 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Bovie Medical Corporation |
| Location | Clearwater, FL |
| Product Type | Devices |
| Quantity | 5894 units |
Product Description
Velocity Disposable Bipolar Ablators - Product Usage: intended to be used for cutting, vaporization, and coagulation of soft tissue during arthroscopic surgical procedures.
Reason for Recall
There can be a potential breach of the sterile packaging barrier due to the development of pinholes at the crease of the double-folded edge of the current package configuration.
Distribution Pattern
US Nationwide distribution in the states of CA and FL.
Lot / Code Information
Catalog Numbers 7201 (lots 0217H, 0317J, 0417B, 0417F, 0417H, 0618K, 0718B, 0718D, 0718F, 0419J, 0519J, 0120F, 0420B, 0720K, 0720M, 0820L, 0117D, 0117F, 1020L); 7205 (lots 0217B, 0317L); 7206 (lots 0217B, 0317L); 7201-01 (lots 0920B, 0920D, 0920H); 7203 (0217F, 0317B, 0317L, 0417H).
Other Recalls from Bovie Medical Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1155-2021 | Class II | ConMed Disposable Bipolar Ablators - Product Us... | Feb 1, 2021 |
| Z-1154-2021 | Class II | HNM Disposable Bipolar Ablators - Product Usage... | Feb 1, 2021 |
| Z-2060-2020 | Class II | Renuvion/ J-Plasma Precise Open Handpiece. Cat... | Apr 20, 2020 |
| Z-2061-2020 | Class II | Renuvion/ J-Plasma Precise Handpiece. Catalog ... | Apr 20, 2020 |
| Z-0198-2019 | Class II | J-Plasma Precise 360, single use, disposable. ... | Jun 18, 2018 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.